» Articles » PMID: 2002553

Absent or Rare Human Immunodeficiency Virus Infection of Bone Marrow Stem/progenitor Cells in Vivo

Overview
Journal J Virol
Date 1991 Apr 1
PMID 2002553
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

An important question in human immunodeficiency virus (HIV) pathogenesis is whether HIV-infected bone marrow CD34+ stem/progenitor cells serve as a significant reservoir of virus in HIV-infected individuals. Our data indicate that infection of bone marrow stem/progenitor cells with HIV occurs rarely, if ever, in vivo. In the present study, CD34+ cells were immunomagnetically purified from the bone marrow of HIV-seropositive individuals, and purified cells or colony-forming cells of the granulocyte/macrophage lineage were analyzed for HIV proviral DNA by the polymerase chain reaction. No HIV DNA was detected in colony-forming cells of the granulocyte/macrophage lineage from HIV-positive patients. Furthermore, no virus was found in CD34(+)-enriched cells from six of seven samples from asymptomatic HIV-infected individuals and four of four samples from patients with AIDS-related complex or AIDS. Thus, infected stem cells are not a major source of persistent HIV and do not account for hematopoietic suppression. These findings have positive implications for the concept of marrow reconstitution with autologous stem cells, genetically engineered for HIV resistance, following marrow-ablative antiviral therapy.

Citing Articles

Consequences of HIV infection in the bone marrow niche.

Herd C, Mellet J, Mashingaidze T, Durandt C, Pepper M Front Immunol. 2023; 14:1163012.

PMID: 37497228 PMC: 10366613. DOI: 10.3389/fimmu.2023.1163012.


P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART.

Menkova-Garnier I, Hocini H, Foucat E, Tisserand P, Bourdery L, Delaugerre C PLoS Pathog. 2016; 12(4):e1005571.

PMID: 27082982 PMC: 4833302. DOI: 10.1371/journal.ppat.1005571.


HIV/AIDS: modified stem cells in the spotlight.

Armijo E, Soto C, Davis B Cell Mol Life Sci. 2014; 71(14):2641-9.

PMID: 24509823 PMC: 11113296. DOI: 10.1007/s00018-014-1572-9.


Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Gibellini D, Clo A, Morini S, Miserocchi A, Ponti C, Re M World J Virol. 2013; 2(2):91-101.

PMID: 24175233 PMC: 3785048. DOI: 10.5501/wjv.v2.i2.91.


Recent developments in human immunodeficiency virus-1 latency research.

Chan C, Dietrich I, Hosie M, Willett B J Gen Virol. 2013; 94(Pt 5):917-932.

PMID: 23364195 PMC: 3709588. DOI: 10.1099/vir.0.049296-0.


References
1.
Civin C, Strauss L, Brovall C, Fackler M, Schwartz J, Shaper J . Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol. 1984; 133(1):157-65. View

2.
Molina J, Scadden D, Sakaguchi M, Fuller B, Woon A, Groopman J . Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood. 1990; 76(12):2476-82. View

3.
Andrews R, Singer J, Bernstein I . Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood. 1986; 67(3):842-5. View

4.
Folks T, Powell D, Lightfoote M, Koenig S, Fauci A, Benn S . Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med. 1986; 164(1):280-90. PMC: 2188205. DOI: 10.1084/jem.164.1.280. View

5.
Scharf S, Horn G, Erlich H . Direct cloning and sequence analysis of enzymatically amplified genomic sequences. Science. 1986; 233(4768):1076-8. DOI: 10.1126/science.3461561. View